Syncore Biotechnology Co. Ltd;HUI-YUAN TSENG;RUEY-KUEN HSIEH;SHI-TING LIN
发明人:
RUEY-KUEN HSIEH,HUI-YUAN TSENG,SHI-TING LIN
申请号：
IL26761319
公开号：
IL267613D0
申请日:
2019.06.24
申请国别(地区):
IL
年份:
2019
代理人:
摘要：
A method of treating refractory or resistant pancreatic cancer by administering: (i) a cationic liposomal formulation comprising one or more cationic lipids and a therapeutically effective amount of paclitaxel； or (ii) a cationic liposomal formulation comprising one or more cationic lipids and a therapeutically effective amount of paclitaxel, and a therapeutically effective amount of gemcitabine.
